Thiagarajan P, Perussia B, De Marco L, Wells K, Trinchieri G
Am J Hematol. 1983 May;14(3):255-69. doi: 10.1002/ajh.2830140307.
We describe five monoclonal antibodies that react with four discrete antigens present on human platelets. Antibodies B2.12 and B59.2 precipitate the glycoprotein IIb-IIIa complex from radiolabeled platelet membrane extracts and inhibit platelet aggregation induced by adenosine diphosphate (ADP), collagen, or epinephrine. The antigen recognized by the two antibodies is present on megakaryocytes but either absent entirely or expressed in small amounts on platelets from Glanzmann's thrombasthenic patients. The antigen recognized by antibody B37.3 is absent from thrombasthenic platelets. Antibody B1.12 reacts with an antigen shared by platelets and 20% of peripheral blood lymphocytes and is a potent inducer of platelet aggregation. Antibody B2.10 reacts specifically with platelets and megakaryocytes but does not affect platelet functions. Thus, these reagents are useful tools in diagnostic and functional studies of both normal and abnormal platelets.
我们描述了五种单克隆抗体,它们可与人类血小板上存在的四种离散抗原发生反应。抗体B2.12和B59.2可从放射性标记的血小板膜提取物中沉淀糖蛋白IIb-IIIa复合物,并抑制由二磷酸腺苷(ADP)、胶原蛋白或肾上腺素诱导的血小板聚集。这两种抗体识别的抗原存在于巨核细胞上,但在Glanzmann血小板无力症患者的血小板上要么完全不存在,要么仅少量表达。血小板无力症血小板缺乏抗体B37.3识别的抗原。抗体B1.12与血小板和20%的外周血淋巴细胞共有的一种抗原发生反应,是血小板聚集的强效诱导剂。抗体B2.10特异性地与血小板和巨核细胞发生反应,但不影响血小板功能。因此,这些试剂是正常和异常血小板诊断及功能研究的有用工具。